Studies have shown metformin’s efficacy in reducing cellular proliferation, inducing cell cycle arrest, and enhancing apoptosis, especially in glioblastoma through mechanisms that include the modulation of the mTOR/S6K1 pathway and direct action on glioblastoma stem cells (GSCs). This evidence concerns the gene RPS6KB1 and glioblastoma.